Is Rambus Inc (RMBS) a risky stock?
As of July 27, 2026, Clavix grades Rambus Inc (RMBS) F for risk, a composite score of 36 out of 100 on an A+ to F scale, which puts RMBS in the "elevated risk" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 27, 2026. Clavix regrades every trading day.
RMBS price, last 3 months
RMBS's daily closes over the past three months. Clavix reads risk from the fundamentals and news behind the price, not the line itself.
The five risk dimensions behind RMBS's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how RMBS scores on each, as of July 27, 2026.
What's moving RMBS's risk right now
Company-specific signals Clavix flags behind RMBS's current grade, drawn from recent news and filings as of July 27, 2026.
The available headlines are about the U.S. Nuclear Regulatory Commission proposing medical-use licensing changes, an NRC correction on reactor licensing, and Oracle winning a $7 billion 10-year Pentagon software contract. None of these items name Rambus or its products, so they don't point to a cle…
The available headlines are about Merck's access plans for an HIV prevention pill, engineering tradeoffs using AWS SES for email outreach, and Boeing/ATP JETS signing a pilot training licensing deal. None of these items mention Rambus, so there's no clear link to the stock from this evidence.
Recent RMBS news
The latest headlines Clavix ingested for Rambus Inc, newest first. These feed the news-sentiment dimension of RMBS's grade.
What a F grade means
On the Clavix A+ to F scale, RMBS's composite of 36 falls in the D band (35–49), read as "elevated risk." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell RMBS or any security. Grades are risk indicators, not predictions of return. Data may be delayed.